FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jo Anne Zujewski

Research Profile

Disorders

Procedures

Chemicals & Drugs

Physiology

Premenopause

Concepts & Ideas

Co-author Network

Publications

TOP 3
Debora Fumagalli; Clifford Hudis; Nola Hylton; Sherene Loi; Stefan Michiels; Zeina Nahleh; Martine Piccart; C Sotiriou; Joseph A Sparano; Jo Anne Zujewski; Philippe L Bedard; Matthew Ellis; Laura Esserman
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.
Mitch Dowsett; Matthew Ellis; Daniel F Hayes; N Lynn Henry; Judith C Hugh; Tracy Lively; Lisa McShane; Torsten O Nielsen; Soon Paik; Frederique Penault-Llorca; Ljudmila Prudkin; Meredith Regan; Janine Salter; Ian E Smith; Christos Sotiriou; Giuseppe Viale; Jo Anne Zujewski; Roger A'Hern; John Bartlett; R Charles Coombes; Jack Cuzick
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
Jo Anne Zujewski; Linda C Harlan; Donna M Morrell; Jennifer L Stevens
Ductal carcinoma in situ: trends in treatment over time in the US.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jo Anne Zujewski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Debora Fumagalli; Clifford Hudis; Nola Hylton; Sherene Loi; Stefan Michiels; Zeina Nahleh; Martine Piccart; C Sotiriou; Joseph A Sparano; Jo Anne Zujewski; Philippe L Bedard; Matthew Ellis; Laura Esserman
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.
The lancet oncology 2012;13(6):e240-8.
2011: Mitch Dowsett; Matthew Ellis; Daniel F Hayes; N Lynn Henry; Judith C Hugh; Tracy Lively; Lisa McShane; Torsten O Nielsen; Soon Paik; Frederique Penault-Llorca; Ljudmila Prudkin; Meredith Regan; Janine Salter; Ian E Smith; Christos Sotiriou; Giuseppe Viale; Jo Anne Zujewski; Roger A'Hern; John Bartlett; R Charles Coombes; Jack Cuzick
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
Journal of the National Cancer Institute 2011;103(22):1656-64.
2011: Jo Anne Zujewski; Linda C Harlan; Donna M Morrell; Jennifer L Stevens
Ductal carcinoma in situ: trends in treatment over time in the US.
Breast cancer research and treatment 2011;127(1):251-7.
2010: Linda C Harlan; Jo Anne Zujewski; Marc T Goodman; Jennifer L Stevens
Breast cancer in men in the United States: a population-based study of diagnosis, treatment, and survival.
Cancer 2010;116(15):3558-68.
2010: Larissa A Korde; Jo Anne Zujewski; Leah Kamin; Sharon Giordano; Susan M Domchek; William F Anderson; John M S Bartlett; Karen Gelmon; Zeina Nahleh; Jonas Bergh; Bruno Cutuli; Giancarlo Pruneri; Worta McCaskill-Stevens; Julie R Gralow; Gabriel Hortobagyi; Fatima Cardoso
Multidisciplinary meeting on male breast cancer: summary and research recommendations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(12):2114-22.
2010: Larissa A Korde; Lara Lusa; Lisa McShane; Peter F Lebowitz; LuAnne Lukes; Kevin A Camphausen; Joel Parker; Sandra M Swain; Kent Hunter; Jo Anne Zujewski
Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer.
Breast cancer research and treatment 2010;119(3):685-99.
2010: Jennifer Eng-Wong; Sally Hunsberger; Jo Anne Zujewski
Triple negative breast cancer: breast cancer research in evolution.
Breast disease 2010;32(1-2):1-4.
2009: Larissa A Korde; Amy Micheli; Ashley W Smith; David Venzon; Sheila A Prindiville; Bart Drinkard; Nancy Sebring; Marcia D Smith; Jo Anne Zujewski; Jennifer Eng-Wong
Recruitment to a physical activity intervention study in women at increased risk of breast cancer.
BMC medical research methodology 2009;9():27.
2008: Brian Leyland-Jones; Christine B Ambrosone; John Bartlett; Matthew J C Ellis; Rebecca A Enos; Adekunle Raji; Michael R Pins; Jo Anne Zujewski; Stephen M Hewitt; John F Forbes; Mark Abramovitz; Sofia Braga; Fatima Cardoso; Nadia Harbeck; Carsten Denkert; Scott D Jewell
Recommendations for collection and handling of specimens from group breast cancer clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5638-44.
2008: Jo Anne Zujewski; Leah Kamin
Trial assessing individualized options for treatment for breast cancer: the TAILORx trial.
Future oncology (London, England) 2008;4(5):603-10.
2008: Jennifer Eng-Wong; Jennifer Orzano-Birgani; Catherine K Chow; David Venzon; Jianhua Yao; Claudia E Galbo; Jo Anne Zujewski; Sheila Prindiville
Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(7):1696-701.
2008: Julie R Gralow; Jo Anne Zujewski; Eric Winer
Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(5):696-7.
2008: Jennifer Eng-Wong; Jo Anne Zujewski
Current NCI-sponsored Cooperative Group trials of endocrine therapies in breast cancer.
Cancer 2008;112(3 Suppl):723-9.
2008: Steven E Come; Aman U Buzdar; James N Ingle; Stephen R D Johnston; Angela Brodie; R Charles Coombes; William R Miller; Kathleen I Pritchard; Eric P Winer; Jo Anne Zujewski; Paul E Goss
Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
Cancer 2008;112(3 Suppl):673-8.
2007: Ahalya Premkumar; David J Venzon; Nilo A Avila; Diane V Johnson; Alan T Remaley; Michele R Forman; Jennifer Eng-Wong; Jo Anne Zujewski; Pamela Stratton
Gynecologic and hormonal effects of raloxifene in premenopausal women.
Fertility and sterility 2007;88(6):1637-44.
2007: Amy V Rapkiewicz; Virginia Espina; Jo Anne Zujewski; Peter F Lebowitz; Armando C Filie; Julia D Wulfkuhle; Kevin A Camphausen; Emanuel F Petricoin; Lance A Liotta; Andrea Abati
The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology.
Cancer 2007;111(3):173-84.
2007: Clifford Hudis; William E Barlow; Joseph P Costantino; Robert J Gray; Kathleen I Pritchard; Judith-Anne W Chapman; Joseph A Sparano; Sally Hunsberger; Rebecca A Enos; Richard D Gelber; Jo Anne Zujewski
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2127-32.
2007: Boris Freidlin; Edward L Korn; Sally Hunsberger; Robert Gray; Scott Saxman; Jo Anne Zujewski
Proposal for the use of progression-free survival in unblinded randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2122-6.
2007: Jo Anne Zujewski
What breast-cancer survivors can expect.
Newsweek 2007;149(14):10-1.
2007: Jeanny B Aragon-Ching; Jo Anne Zujewski
CNS metastasis: an old problem in a new guise.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1644-7.
2006: Robert T Chatterton; Jo Anne Zujewski; Esnar T Mateo; Jennifer Eng-Wong; V Craig Jordan
Effect of raloxifene on salivary sex steroid concentrations in premenopausal women.
The Journal of endocrinology 2006;191(3):599-604.
2006: Jennifer Eng-Wong; James C Reynolds; David Venzon; David J Liewehr; S Gantz; David N Danforth; Edison Liu; Catherine Chow; Jo Anne Zujewski
Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer.
The Journal of clinical endocrinology and metabolism 2006;91(10):3941-6.
2006: Jo Anne Zujewski; Rebecca A Enos; Schoenfeldt Mason
Clinical trials referral resource. Current phase III breast cancer clinical trials.
Oncology (Williston Park, N.Y.) 2006;20(7):696, 700, 702.
2006: Jessica M Faupel-Badger; Sheila A Prindiville; David Venzon; Barbara K Vonderhaar; Jo Anne Zujewski; Jennifer Eng-Wong
Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(6):1153-8.
2006: Suparna Bonthala Wedam; Jennifer A Low; Sherry X Yang; Catherine K Chow; Peter Choyke; David N Danforth; Stephen M Hewitt; Arlene Berman; Seth M Steinberg; David J Liewehr; Jonathan Plehn; Arpi Doshi; David Thomasson; Nicole J McCarthy; Hartmut Koeppen; Mark Sherman; Jo Anne Zujewski; Kevin A Camphausen; Helen Chen; Sandra M Swain
Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(5):769-77.
2005: Jo Anne Zujewski; Jennifer Eng-Wong
Sentinel lymph node biopsy in the management of ductal carcinoma in situ.
Clinical breast cancer 2005;6(3):216-22.
2005: Peter F Lebowitz; Jennifer Eng-Wong; BRIGITTE WIDEMANN; FRANK BALIS; Nalini Jayaprakash; Catherine Chow; Geoff Clark; Susan B Gantz; David Venzon; Jo Anne Zujewski
A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1247-52.
2004: Peter F Lebowitz; Jennifer Eng-Wong; Sandra M Swain; Arlene Berman; Maria J Merino; Catherine K Chow; David Venzon; Farah zia; David N Danforth; Edison Liu; Jo Anne Zujewski
A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):6764-9.
2004: Larissa A Korde; Kathleen A Calzone; Jo Anne Zujewski
Assessing breast cancer risk: genetic factors are not the whole story.
Postgraduate medicine 2004;116(4):6-8, 11-4, 19-20.
2004: M W Saif; Susan F Leitman; Georgia Cusack; M Horne; A Freifeld; D Venzon; Ahalya Premkumar; K H Cowan; R E Gress; Jo Anne Zujewski; Claude Kasten-Sportes
Thromboembolism following removal of femoral venous apheresis catheters in patients with breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(9):1366-72.
2004: Jennifer Eng-Wong; Jo Anne Zujewski
Raloxifene and its role in breast cancer prevention.
Expert review of anticancer therapy 2004;4(4):523-32.
2003: Jennifer Eng-Wong; Stephen D Hursting; David Venzon; Susan N Perkins; Jo Anne Zujewski
Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(12):1468-73.
2003: Peter F Lebowitz; Jo Anne Zujewski
Hormonal therapy of breast cancer.
Current problems in cancer 2003;27(6):279-331.
2003: Jo Anne Zujewski; Jennifer Eng-Wong; Joyce A O'Shaughnessy; David Venzon; Catherine Chow; David N Danforth; David R Kohler; Georgia Cusack; David Riseberg; Kenneth H Cowan
A pilot study of dose intense doxorubicin and cyclophosphamide followed by infusional paclitaxel in high-risk primary breast cancer.
Breast cancer research and treatment 2003;81(1):41-51.
2003: David N Danforth; Kenneth H Cowan; Rosemary M Altemus; Maria Merino; Catherine Chow; Arlene Berman; Usha Chaudhry; Craig Shriver; Seth M Steinberg; Jo Anne Zujewski
Preoperative FLAC/granulocyte-colony-stimulating factor chemotherapy for stage II breast cancer: a prospective randomized trial.
Annals of surgical oncology 2003;10(6):635-44.
2003: Gregory D Leonard; Jo Anne Zujewski
Docetaxel-related skin, nail, and vascular toxicity.
The Annals of pharmacotherapy 2003;37(1):148.
2002: David N Danforth; Luigi Aloj; Jorge Carrasquillo; Stephen L Bacharach; Catherine Chow; Jo Anne Zujewski; Millie Whatley; Barbara Galen; Maria Merino; Ronald D Neumann
The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer.
Breast cancer research and treatment 2002;75(2):135-46.
2002: Jo Anne Zujewski
"Build quality in"--HER2 testing in the real world.
Journal of the National Cancer Institute 2002;94(11):788-9.
2002: Jo Anne Zujewski
Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention.
Environmental and molecular mutagenesis 2002;39(2-3):264-70.
2001: JA Lawrence; Peter Charles Adamson; R Caruso; Catherine Chow; David Kleiner; RF Murphy; David J Venzon; M Shovlin; MH Noone; Maria Merino; Kenneth H Cowan; M Kaiser; Joyce A O'Shaughnessy; Jo Anne Zujewski
Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2754-63.
2001: Jo Anne Zujewski; A Vaughn-Cooke; Kathleen C Flanders; Michael Eckhaus; Ronald A Lubet; Lalage M Wakefield
Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system.
Breast cancer research : BCR 2001;3(1):66-75.
2000: Catherine K Chow; David Venzon; Elizabeth C Jones; Ahalya Premkumar; Joyce A O'Shaughnessy; Jo Anne Zujewski
Effect of tamoxifen on mammographic density.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(9):917-21.
2000: Jo Anne Zujewski; ID Horak; CJ Bol; R Woestenborghs; Charlie Bowden; David W End; V K Piotrovsky; J Chiao; Robert T Belly; A Todd; William Kopp; David R Kohler; Catherine Chow; MH Noone; Frances T Hakim; G Larkin; Ronald E Gress; Robert B Nussenblatt; A B Kremer; Kenneth H Cowan
Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):927-41.
2000: BA Conley; Joyce A O'Shaughnessy; Sheila A Prindiville; J Lawrence; Catherine Chow; E Jones; Maria J Merino; Muriel I Kaiser-Kupfer; Rafael C Caruso; MJ Podgor; Barry Goldspiel; David Venzon; David N Danforth; Suhlan Wu; MH Noone; J Goldstein; Kenneth H Cowan; Jo Anne Zujewski
Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(2):275-83.
1999: Jo Anne Zujewski; L Pai; Lalage M Wakefield; Ruthann M Giusti; F A Dorr; C Flanders; R Caruso; M Kaiser; L Goodman; Maria Merino; M Gossard; M A Noone; Andrea M Denicoff; David Venzon; Kenneth H Cowan; Joyce A O'Shaughnessy
Tamoxifen and fenretinide in women with metastatic breast cancer.
Breast cancer research and treatment 1999;57(3):277-83.
1999: Kenneth H Cowan; Jeffrey A Moscow; H Huang; Jo Anne Zujewski; Joyce A O'Shaughnessy; Brian P Sorrentino; Kenneth Hines; Charles Carter; E Schneider; Georgia Cusack; MH Noone; Cynthia Dunbar; S Steinberg; Wyndham Wilson; Barry Goldspiel; Elizabeth J Read; Susan F Leitman; Kevin T McDonagh; Catherine Chow; Andrea Abati; Y Chiang; Y N Chang; Michael M Gottesman; Ira Pastan; Arthur W Nienhuis
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1619-28.
1999: Jeffrey A Moscow; H Huang; Charles Carter; Kenneth Hines; Jo Anne Zujewski; Georgia Cusack; Catherine Chow; David Venzon; Brian P Sorrentino; Y Chiang; Barry Goldspiel; Susan F Leitman; Elizabeth J Read; Andrea Abati; Michael M Gottesman; Ira Pastan; Stephanie Sellers; Cynthia Dunbar; Kenneth H Cowan
Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy.
Blood 1999;94(1):52-61.
1998: Gretchen N Schwartz; M K Warren; S W Rothwell; Jo Anne Zujewski; D C Halverson; Kenneth H Cowan; A Tolcher; Joyce A O'Shaughnessy; Ronald E Gress
Post-chemotherapy and cytokine pretreated marrow stromal cell layers suppress hematopoiesis from normal donor CD34+ cells.
Bone marrow transplantation 1998;22(5):457-68.
1998: Rafael C Caruso; Jo Anne Zujewski; Fumino Iwata; MJ Podgor; BA Conley; L M Ayres; Muriel I Kaiser-Kupfer
Effects of fenretinide (4-HPR) on dark adaptation.
Archives of ophthalmology 1998;116(6):759-63.
1998: David N Danforth; Jo Anne Zujewski; Joyce A O'Shaughnessy; D Riseberg; Seth M Steinberg; N McAtee; MH Noone; Catherine Chow; U Chaudhry; Marc Lippman; J Jacobson; P Okunieff; Kenneth H Cowan
Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer.
Annals of surgical oncology 1998;5(2):150-8.
1998: Jo Anne Zujewski; A Nelson; Jeffrey Abrams
Much ado about not...enough data: high-dose chemotherapy with autologous stem cell rescue for breast cancer.
Journal of the National Cancer Institute 1998;90(3):200-9.
1997: Frances T Hakim; R Cepeda; S Kaimei; CRYSTAL MACKALL; N McAtee; Jo Anne Zujewski; Kenneth H Cowan; Ronald E Gress
Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells.
Blood 1997;90(9):3789-98.
1997: RV Emmons; S Doren; Jo Anne Zujewski; M Cottler-Fox; Charles S Carter; Kenneth Hines; Joyce A O'Shaughnessy; Susan F Leitman; J J Greenblatt; Kenneth H Cowan; Cynthia E Dunbar
Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo.
Blood 1997;89(11):4040-6.
1997: A W Tolcher; Joyce A O'Shaughnessy; R B Weiss; Jo Anne Zujewski; R C Myhand; E Schneider; Frances T Hakim; Ronald E Gress; Barry Goldspiel; MH Noone; L R Brewster; M R Gossard; Kenneth H Cowan
A phase I study of topotecan followed sequentially by doxorubicin in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):755-60.
1997: Cynthia E Dunbar; John F Tisdale; JM Yu; T Soma; Jo Anne Zujewski; David M Bodine; Stephanie Sellers; Kenneth H Cowan; R Donahue; RV Emmons
Transduction of hematopoietic stem cells in humans and in nonhuman primates.
Stem cells (Dayton, Ohio) 1997;15 Suppl 1():135-9; discussion 139-40.
1996: Frances T Hakim; R Childs; J Balow; Kenneth H Cowan; Jo Anne Zujewski; Ronald E Gress
Development of paroxysmal nocturnal hemoglobinuria after chemotherapy.
Blood 1996;88(12):4725-6.
1996: I Weinberg; S Majewski; A Weisenberger; A Markowitz; Luigi Aloj; L Majewski; D Danforth; J Mulshine; Kenneth H Cowan; Jo Anne Zujewski; Catherine Chow; E Jones; V Chang; Wendie A Berg; J Frank
Preliminary results for positron emission mammography: real-time functional breast imaging in a conventional mammography gantry.
European journal of nuclear medicine 1996;23(7):804-6.
1996: Joyce A O'Shaughnessy; A Tolcher; D Riseberg; David Venzon; Jo Anne Zujewski; MH Noone; M Gossard; D Danforth; J Jacobson; V Chang; Barry Goldspiel; P Keegan; R Giusti; Kenneth H Cowan
Prospective, randomized trial of 5-fluorouracil, leucovorin, doxorubicin, and cyclophosphamide chemotherapy in combination with the interleukin-3/granulocyte-macrophage colony-stimulating factor (GM-CSF) fusion protein (PIXY321) versus GM-CSF in patients with advanced breast cancer.
Blood 1996;87(6):2205-11.
1996: Gretchen N Schwartz; Frances T Hakim; Jo Anne Zujewski; J M Szabo; R Cepada; D Riseberg; M K Warren; CRYSTAL MACKALL; A Setzer; MH Noone; Kenneth H Cowan; Joyce A O'Shaughnessy; Ronald E Gress
Early suppressive effects of chemotherapy and cytokine treatment on committed versus primitive haemopoietic progenitors in patient bone marrow.
British journal of haematology 1996;92(3):537-47.
1996: M K Warren; Jo Anne Zujewski; W L Rose; J M Szabo; Joyce A O'Shaughnessy; D C Halverson; Kenneth H Cowan; Ronald E Gress; Gretchen N Schwartz
Early suppressive effects of chemotherapy on recovery of bone marrow megakaryocyte precursors: possible relationship to platelet recovery.
Stem cells (Dayton, Ohio) 1996;14 Suppl 1():31-7.
1996: A W Tolcher; Kenneth H Cowan; MH Noone; A M Denicoff; David R Kohler; Barry Goldspiel; C S Barnes; M McCabe; M R Gossard; Jo Anne Zujewski; Joyce A O'Shaughnessy
Phase I study of paclitaxel in combination with cyclophosphamide and granulocyte colony-stimulating factor in metastatic breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):95-102.